Product Information
METRONIDAZOLE 500 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1043 per EA under NDC 16571066450. Its NADAC has been published 331 times since Jun 3, 2020.
FDA first approved this application on May 29, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571066450
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203974FDA Approved
5/29/2015
TE Code
AB
On Market Since
5/29/2015
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 500 MG TABLET has been published 331 times since Jun 3, 2020, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1043 per EA |
|---|---|
| All-time high | $0.2130 (Dec 16, 2020) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1043 |
| 52-week low | $0.0999 |
| Median price | $0.1314 |
| Average price | $0.1304 |
| Largest weekly change | +39.1% (Jun 19, 2024) |
| Weeks tracked | 331 |
| Tracking since | Jun 3, 2020 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metronidazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 500 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1043 per EA (NDC 16571066450), effective Sep 30, 2026.
How has the price of METRONIDAZOLE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 500 MG TABLET has declined 21.1%. It has been tracked across 331 weekly CMS publications since Jun 3, 2020.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 500 MG TABLET?
Since Jun 3, 2020, the NADAC for METRONIDAZOLE 500 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.2130 (Dec 16, 2020), with a median of $0.1314 per EA.
Are there cheaper alternatives to METRONIDAZOLE 500 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METRONIDAZOLE 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METRONIDAZOLE 500 MG TABLET?
METRONIDAZOLE 500 MG TABLET (NDC 16571066450) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.